{"gene":"HMGB2","run_date":"2026-04-28T18:06:53","timeline":{"discoveries":[{"year":1978,"finding":"HMG1 and HMG2 reduce the linking number of circular DNA when present during covalent closure, demonstrating they can unwind the DNA double helix or induce supercoiling.","method":"Topological winding number assay with circular DNA","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 — direct biochemical assay, foundational finding replicated in subsequent work","pmids":["628842"],"is_preprint":false},{"year":1979,"finding":"HMG1 and HMG2 unwind the DNA double helix by local denaturation of base pairs; net unwinding angles measured at 22° and 26° per molecule for HMG1 and HMG2 respectively; HMG1 has higher affinity for single-stranded vs. double-stranded DNA.","method":"Melting absorption technique, competition unwinding experiments","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 — quantitative in vitro biochemical assay","pmids":["226939"],"is_preprint":false},{"year":1993,"finding":"HMG1 and HMG2 promote assembly of complex nucleoprotein structures by bending DNA extremely efficiently, forming circles as small as 59–66 bp; HMG box B domain of HMG1 is sufficient for DNA bending and invertasome assembly; they can substitute for the prokaryotic HU protein in Hin-mediated site-specific DNA inversion.","method":"Invertasome assembly assay, ligase-mediated circularization assay, partial proteolytic digestion domain analysis","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal in vitro assays with domain dissection, highly cited foundational paper","pmids":["8339930"],"is_preprint":false},{"year":1994,"finding":"HMG2 acts as a basal repressor of class II gene transcription by inhibiting transcription after assembly of a TBP-TFIIA-promoter complex but before formation of the fourth phosphodiester bond by RNA Pol II; a TFIIH-associated factor counteracts this repression in an ATP-dependent manner.","method":"In vitro transcription reconstitution, order-of-addition experiments, antibody depletion, ATP analog inhibition","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro transcription system with multiple mechanistic controls","pmids":["8007973"],"is_preprint":false},{"year":1995,"finding":"HMG-2 was identified as a factor necessary for transcriptional activation in a defined in vitro RNA Pol II system; activation requires TFIIA and TAFs within TFIID; HMG-2 stabilizes an activated conformation of the TFIID-TFIIA-promoter complex; TFIIB dissociates more slowly from the activated preinitiation complex.","method":"In vitro transcription with purified factors, TFIIB titration, preinitiation complex analysis","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1 — reconstituted defined in vitro transcription system","pmids":["7797075"],"is_preprint":false},{"year":1997,"finding":"Nuclear accumulation of HMG2 is mediated by basic regions interspaced with the HMG1/2 box DNA-binding sequence acting as a novel nuclear localization signal; retention within the nucleus requires the acidic carboxyl terminus, demonstrated by interspecies heterokaryon assay.","method":"HMG2-β-galactosidase fusion protein expression in COS-7 cells, deletion analysis, interspecies heterokaryon assay","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 2 — deletion analysis in living cells with heterokaryon functional validation","pmids":["9166769"],"is_preprint":false},{"year":1998,"finding":"HMG2 enhances the nuclease activity of DFF40/CAD during apoptosis, suggesting HMG proteins augment DNA fragmentation through changes in chromosome structure.","method":"Biochemical identification and in vitro nuclease activity assay with bacterially expressed HMG2","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro reconstitution assay, single lab single method","pmids":["9784391"],"is_preprint":false},{"year":1999,"finding":"The RAG1 homeodomain directly interacts with both HMG boxes of HMG1 and HMG2; this interaction facilitates RAG1/RAG2 binding to the recombination signal sequence, mainly by promoting high-affinity binding to the nonamer motif; HMG1/2 significantly enhance binding and bending of the 23RSS; transient HMG1/2 overexpression increases V(D)J recombination in vivo.","method":"Co-immunoprecipitation/direct interaction assay, electrophoretic mobility shift assay, circular permutation assay, transfection experiment","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — reciprocal binding assays, in vivo validation, multiple orthogonal methods","pmids":["10490593"],"is_preprint":false},{"year":1999,"finding":"A dimer of RAG1 stably incorporates HMG2 into the RAG1-RSS complex; HMG2 can increase the affinity of RAG1 for the RSS in the absence of RAG2.","method":"Electrophoretic mobility shift assay, recombinant protein expression, zinc analysis","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 — direct biochemical binding assays, single lab","pmids":["10390537"],"is_preprint":false},{"year":1999,"finding":"HMG2 box B is the main domain for DNA recognition and conformational changes (preferential binding to negatively supercoiled DNA, DNA unwinding); box A does not possess these activities alone; Phe-102 in box B intercalates into the base stack whereas Ala-16 in box A cannot.","method":"Gel retardation, DNA supercoiling assay, surface plasmon resonance (SPR) binding kinetics, computer modeling, recombinant peptide expression","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal in vitro assays with mutagenesis/domain dissection and structural modeling","pmids":["9888798"],"is_preprint":false},{"year":2001,"finding":"HMGB1 physically interacts with p73α and p73β (both splice variants); both HMG box domains A and B of HMGB1 interact with p73α; HMGB1 enhances binding of p73 to specific cognate DNA sites; endogenous HMGB1 and HMGB2 inhibit p73α/β- and p53-dependent transactivation from the Bax gene promoter in a cell- and promoter-specific manner.","method":"Pull-down assay, gel-shift assay, transient transfection with antisense strategy, reporter gene assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — reciprocal pull-down plus functional transcription assays, multiple cell lines","pmids":["11748232"],"is_preprint":false},{"year":2001,"finding":"Male Hmgb2-/- mice have reduced fertility with Sertoli and germ cell degeneration in seminiferous tubules and immotile spermatozoa; HMGB2 is expressed at very high levels in primary spermatocytes but barely detectable in spermatogonia and elongated spermatids, indicating a specialized role in germ cell differentiation.","method":"Knockout mouse (Hmgb2-/-) phenotypic analysis, histology, immunostaining, expression analysis","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 — clean genetic knockout with defined cellular phenotype, replicated findings","pmids":["11262228"],"is_preprint":false},{"year":2002,"finding":"HMG2 is a component of the SET complex (endoplasmic reticulum-associated ~270-420 kDa complex containing SET, pp32, and APE); HMG2 coprecipitates with SET; cytoplasmic HMG2 colocalizes with SET at the ER; HMG2 provides the DNA bending and looping activities of the SET complex; HMG2 (but not HMG1) is a substrate of granzyme A, which cleaves after Lys65 in HMG box A, destroying DNA binding and bending functions.","method":"Co-immunoprecipitation, confocal microscopy colocalization, in vitro granzyme A cleavage assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP, colocalization imaging, biochemical cleavage assay with functional consequence","pmids":["11909973"],"is_preprint":false},{"year":2003,"finding":"HMGB1 and HMGB2 are present in two forms in mitotic cells—free and associated with condensed chromatin—that rapidly exchange; for HMGB2, two sites encompassing HMG-box A and B are responsible for binding to mitotic chromosomes; this interaction is rapidly inactivated by cell permeabilization or chemical fixation.","method":"Live-cell imaging with GFP/DsRed-tagged proteins, fluorescence recovery after photobleaching (FRAP)","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 — live-cell imaging with domain mapping, multiple fluorescent tags","pmids":["12925773"],"is_preprint":false},{"year":2005,"finding":"Isolated HMG box A from HMGB2 binds DNA in two modes: a flexible hinge mode at low protein concentrations (inducing average DNA bend of 114° at 50 mM Na+ or 87° at 100 mM Na+ and increasing DNA contour length) and a cooperative filament mode at higher concentrations.","method":"Optical tweezers single-molecule DNA stretching assay","journal":"Biophysical journal","confidence":"High","confidence_rationale":"Tier 1 — single-molecule biophysical measurement with quantitative parameters","pmids":["15833996"],"is_preprint":false},{"year":2009,"finding":"HMGB2 is uniquely expressed in the superficial zone (SZ) of articular cartilage; aging-related loss of HMGB2 leads to increased chondrocyte apoptosis and earlier onset of more severe osteoarthritis in Hmgb2-/- mice; HMGB2 supports chondrocyte survival.","method":"Hmgb2-/- knockout mouse analysis, immunohistochemistry, in vitro apoptosis induction assay, histological scoring","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined cellular phenotype (apoptosis) and in vitro validation","pmids":["19139395"],"is_preprint":false},{"year":2009,"finding":"HMGB2 enhances binding of Lef-1 to its target sequence and potentiates transcriptional activation of the Lef-1/β-catenin complex; the HMG domain of HMGB2 is required for interaction with Lef-1; HMGB2 and Wnt/β-catenin signaling co-localize specifically in the superficial zone of articular cartilage; conditional deletion of β-catenin in chondrocytes induces apoptosis.","method":"Luciferase reporter assay, electrophoretic mobility shift assay, immunofluorescence co-localization, conditional knockout mouse","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods establishing direct protein-protein interaction and functional transcriptional consequence","pmids":["19805379"],"is_preprint":false},{"year":2009,"finding":"HMGB1 and HMGB2 up-regulate cellular expression of topoisomerase IIα; HMGB2 modulates binding of transcription factor NF-Y to the topo IIα promoter; HMGB1 DNA-bending activity is required for topo IIα promoter activation; this activation is inhibited by pRb.","method":"Knockdown of HMGB1/2 (siRNA), reporter assay, RT-PCR, Western blot, ChIP","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 — knockdown with defined molecular phenotype, promoter analysis, multiple cell lines","pmids":["19223331"],"is_preprint":false},{"year":2009,"finding":"Acetylated forms of HMGB1 and HMGB2 acquire the ability to bind core nucleosomal particles (a property absent in non-acetylated proteins); acetylated HMGB1/2 show stronger binding to linker DNA-containing nucleosomes and higher co-remodeling activity with SWI/SNF and RSC; acetylation enhances SWI/SNF binding to the nucleosome without affecting its ATPase activity.","method":"Nucleosome binding assay, SWI/SNF/RSC-dependent nucleosome mobilization assay, ATPase activity measurement","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with post-translational modification functional consequence","pmids":["19522541"],"is_preprint":false},{"year":2009,"finding":"HMGB2 regulates erythroid differentiation by binding to the GFI1B promoter in vivo and up-regulating its trans-activation by enhancing binding of Oct-1 and, to a lesser extent, GATA-1 and NF-Y; HMGB2 knockdown in hematopoietic progenitors leads to decreased Gfi-1B expression and impaired erythroid differentiation.","method":"ChIP (in vivo promoter binding), electrophoretic mobility shift assay, shRNA knockdown, differentiation assay","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — ChIP plus functional EMSA and loss-of-function differentiation phenotype","pmids":["19965638"],"is_preprint":false},{"year":2011,"finding":"HMGB2 suppresses chondrogenic differentiation of mesenchymal stem cells; HMGB2 negatively regulates the stimulatory effect of Wnt/β-catenin signaling on the Runx2 proximal promoter; loss of HMGB2 accelerates osteogenesis and chondrogenic hypertrophy (enhanced Col10a1 and Runx2 expression) in MSC.","method":"Lentiviral HMGB2 transduction, Hmgb2-/- mouse MSC differentiation assays, reporter assay for Runx2 promoter","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — gain- and loss-of-function with defined molecular promoter mechanism","pmids":["21890638"],"is_preprint":false},{"year":2012,"finding":"HMGB2 knockdown sensitizes colorectal cancer cells to ionizing radiation by increasing DNA damage and impairing DNA damage repair; p53 directly down-regulates HMGB2 promoter activity (confirmed by luciferase reporter and Nutlin-3/Tet-On p53 induction); radiation downregulates HMGB2 in TP53-intact but not TP53-mutant cells.","method":"shRNA knockdown, clonogenic assay, DNA damage markers, luciferase reporter assay, Nutlin-3 treatment, Tet-On p53 induction","journal":"Cancer biology & therapy","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods linking p53, HMGB2 promoter regulation, and DNA repair function","pmids":["23255232"],"is_preprint":false},{"year":2013,"finding":"Oct4 post-translational modifications (phosphorylation and sumoylation) regulate its interaction with Hmgb2 and the SET complex; this promotes Akt activation and preserves H3K27me3 modifications in daughter progeny to maintain pluripotency in murine embryonic stem cells.","method":"Co-immunoprecipitation, phosphorylation mutant analysis, Akt activity assays, chromatin immunoprecipitation (H3K27me3)","journal":"Stem cells","confidence":"Medium","confidence_rationale":"Tier 2 — co-IP with functional epistasis, single lab","pmids":["23495099"],"is_preprint":false},{"year":2014,"finding":"HMGB2 interacts with SRC-1 and the oestrogen receptor (ER) in the endocrine-resistant setting; HMGB2/SRC-1/ER complex is enriched at promoter regions of target genes including the RNA helicase DDX18; modulation of DDX18 directly affects growth of tamoxifen-resistant cells.","method":"ChIP-seq (HMGB2), co-immunoprecipitation, gene expression integration, siRNA knockdown","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 — ChIP-seq plus co-IP and functional downstream target validation","pmids":["25284587"],"is_preprint":false},{"year":2015,"finding":"Lrp1-AS (antisense lncRNA) directly binds to HMGB2 and inhibits its activity to enhance Srebp1a-dependent transcription of Lrp1; short oligonucleotides targeting Lrp1-AS inhibit the lncRNA-HMGB2 interaction and increase Lrp1 expression.","method":"RNA-protein binding assay, co-immunoprecipitation, reporter assay, oligonucleotide targeting","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 — direct RNA-protein interaction demonstrated with functional transcriptional consequence","pmids":["25937287"],"is_preprint":false},{"year":2016,"finding":"HMGB2 preferentially localizes to SASP gene loci during senescence; loss of HMGB2 allows repressive heterochromatin to spread into SASP gene loci, incorporating them into SAHF and blunting SASP gene expression; HMGB2 acts as a master regulator of SASP by preventing heterochromatin spreading.","method":"ChIP-seq, siRNA knockdown, Hi-C, immunofluorescence, gene expression analysis","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 — ChIP-seq with functional loss-of-function showing chromatin and transcriptional consequences","pmids":["27799366"],"is_preprint":false},{"year":2016,"finding":"HMGB2 is an essential nuclear transcriptional co-regulator in myogenesis; HMGB2 promotes Myf5 and cyclin A2 protein levels (not mRNA) by inducing IGF2BP2, an RNA-binding protein that enhances Myf5 mRNA translation and cyclin A2 mRNA stabilization; HMGB2 depletion in vivo reduces satellite cells and impairs muscle repair.","method":"siRNA/shRNA knockdown, overexpression, Western blot, RT-PCR, rescue experiment with IGF2BP2, in vivo muscle injury model","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 2 — epistasis rescue experiment, in vivo knockout phenotype, defined molecular mechanism","pmids":["27672022"],"is_preprint":false},{"year":2018,"finding":"Nuclear depletion of HMGB2 occurs early on the path to senescence and coincides with dramatic spatial clustering of CTCF; HMGB2 knockdown is sufficient to induce senescence-associated CTCF clustering and loop reshuffling; ectopic HMGB2 expression rescues these effects.","method":"Hi-C, single-cell transcriptomics, imaging, in silico modeling, HMGB2 knockdown and rescue experiments across three cell types","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal genome-wide methods, rescue experiments, three cell types","pmids":["29706538"],"is_preprint":false},{"year":2009,"finding":"HMGB2 stabilizes p53 in HPV-positive HeLa cells by interfering with E6/E6AP-mediated ubiquitination and degradation of p53; HMGB2 overexpression leads to G1 cell cycle arrest; this effect is specific to HPV-positive cells.","method":"Co-expression experiment, ubiquitination assay, siRNA knockdown, FACS cell cycle analysis","journal":"Cancer letters","confidence":"Medium","confidence_rationale":"Tier 2 — direct mechanistic experiment with ubiquitination assay, single lab","pmids":["20036050"],"is_preprint":false},{"year":2017,"finding":"HMGB2 promotes neointimal hyperplasia and VSMC proliferation/migration by inducing reactive oxygen species through increased p47phox phosphorylation; HMGB2-induced effects are mediated via RAGE (receptor for advanced glycation end products) but not TLR4, as RAGE knockdown/deficiency but not TLR4 knockdown abolished HMGB2 effects.","method":"Hmgb2-/- mouse arterial injury model, perivascular HMGB2 administration, siRNA knockdown of p47phox and RAGE/TLR4, ROS measurement","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"High","confidence_rationale":"Tier 2 — in vivo KO plus in vitro mechanistic dissection with receptor and effector knockdown","pmids":["28183701"],"is_preprint":false},{"year":2018,"finding":"HMGB2 promotes myocardial ischemic injury by stimulating ROS production via RAGE signaling, thereby aggravating cell apoptosis, inflammation, and autophagosome clearance impairment; RAGE knockdown abolishes HMGB2-induced effects.","method":"Intramyocardial injection of HMGB2 in MI rat model, NADPH oxidase inhibitor (apocynin) co-administration, RAGE knockdown","journal":"American journal of physiology. Heart and circulatory physiology","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo injection model with inhibitor and receptor knockdown, single lab","pmids":["28011583"],"is_preprint":false},{"year":2018,"finding":"Hmgb2-/- mice show cardiac dysfunction due to AKT inactivation and decreased SERCA2a activity; HMGB2 loss worsens pressure overload-induced heart failure after TAC surgery, indicating HMGB2 plays a cardioprotective role via AKT/SERCA2a pathway.","method":"Hmgb2-/- knockout mouse, TAC surgery model, Western blot for AKT activation and SERCA2a activity, echocardiography","journal":"Circulation journal","confidence":"Medium","confidence_rationale":"Tier 2 — clean KO with defined molecular pathway, single lab","pmids":["30487376"],"is_preprint":false},{"year":2018,"finding":"HMGB2 mediates adipogenesis by enhancing expression of C/EBPβ through direct binding to the 'GGGTCTCAC' sequence in its promoter specifically during the mitotic clonal expansion stage; exogenous C/EBPβ rescues adipogenic defects caused by HMGB2 inhibition.","method":"ChIP assay (HMGB2 binding to C/EBPβ promoter), Hmgb2-/- mouse, promoter reporter assay, rescue experiment","journal":"Cell death & disease","confidence":"High","confidence_rationale":"Tier 2 — ChIP with defined binding sequence plus epistasis rescue, in vivo KO","pmids":["34215724"],"is_preprint":false},{"year":2019,"finding":"HMGB2 is a transcriptional suppressor of latexin in hematopoietic stem cells; HMGB2 identified by DNA pull-down and mass spectrometry as binding the latexin promoter; HMGB2 knockdown increases latexin expression and decreases HSC number and regeneration; a functional SNP (rs31528793) in the latexin promoter affects HMGB2 binding and promoter activity.","method":"DNA pull-down followed by mass spectrometry, ChIP, siRNA knockdown, in vivo HSC number and regeneration assay, SNP promoter assay","journal":"Haematologica","confidence":"High","confidence_rationale":"Tier 2 — DNA pull-down/MS identification plus ChIP, functional in vivo validation","pmids":["31171637"],"is_preprint":false},{"year":2019,"finding":"HMGB2 is a negative regulator of telomerase activity in human embryonic stem cells and neuroectodermal progenitors; HMGB2 deficiency activates PI3K/AKT/GSK-3β/β-catenin signaling and augments TERT/TERC transcription; HMGB2 and HMGB1 have opposing roles in telomerase regulation.","method":"shRNA-mediated knockdown in stably transfected hESCs, telomerase activity assay, RT-PCR, Western blot, TERRA measurement","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 — defined KD phenotype with pathway analysis, single lab","pmids":["31661640"],"is_preprint":false},{"year":2018,"finding":"lnc-CRCMSL physically binds to HMGB2 (identified by RNA pulldown) and stabilizes HMGB2 in the cytoplasm; lnc-CRCMSL knockdown shifts HMGB2 to the nucleus where it triggers EMT programming by interacting with OCT4; nuclear export inhibitor (leptomycin B) counteracts lnc-CRCMSL-mediated suppression of EMT, confirming that cytoplasmic retention of HMGB2 is the key mechanism.","method":"RNA pulldown, subcellular fractionation, co-immunoprecipitation (HMGB2-OCT4), leptomycin B treatment, in vivo tumor model","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 — RNA pulldown plus pharmacological validation of nucleocytoplasmic shuttling mechanism","pmids":["30575817"],"is_preprint":false},{"year":2023,"finding":"HMGB2 regulates the differentiation and maintenance of stem-like progenitor exhausted CD8+ T cells (Tpex) during chronic viral infection and cancer through epigenetic and transcriptional programming; HMGB2 acts cell-intrinsically—despite Hmgb2-/- CD8+ T cells expressing TCF-1 and TOX, these master regulators cannot sustain Tpex differentiation.","method":"Hmgb2-/- mouse, chronic LCMV infection model, tumor model, single-cell transcriptomics, ATAC-seq epigenetic profiling","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — clean KO, in vivo chronic infection and tumor models, epigenetic profiling","pmids":["37704621"],"is_preprint":false},{"year":2024,"finding":"NAT10-mediated N4-acetylcytidine (ac4C) modification within the coding sequence of HMGB2 mRNA enhances HMGB2 translation by facilitating eukaryotic elongation factor 2 (eEF2) binding to the ac4C sites.","method":"Acetylated RNA immunoprecipitation sequencing (acRIP-seq), ribosome profiling, RNA immunoprecipitation, RNA pull-down, mass spectrometry, site-specific mutation analysis","journal":"Cancer communications","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal methods including ribosome profiling, RNA pulldown, and site-specific mutagenesis","pmids":["39030964"],"is_preprint":false},{"year":2022,"finding":"HMGB2 is predominantly expressed in the outer nuclear layer of the retina and is released to the cytoplasm after oxidative injury; exogenous HMGB2 reduces Nrf2 and HO-1 expression and activates the NF-κB/NLRP3 pathway; HMGB2 knockdown increases cell viability, up-regulates Nrf2/HO-1, and down-regulates pyroptosis-related proteins in H2O2-treated cells.","method":"Mouse light-induced retinal damage model, siRNA knockdown, recombinant HMGB2 protein treatment, Western blot, immunofluorescence","journal":"Free radical biology & medicine","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo model plus in vitro gain/loss-of-function, single lab","pmids":["35091064"],"is_preprint":false}],"current_model":"HMGB2 is a non-histone chromatin architectural protein that bends and unwinds DNA via its two HMG box domains (box B being the primary DNA-recognition and conformational-change domain), facilitates assembly of nucleoprotein complexes (including RAG1/2-RSS, SET complex, and Lef-1/β-catenin), modulates transcription of specific gene programs (GFI1B in erythropoiesis, C/EBPβ in adipogenesis, SASP genes in senescence, topo IIα, and Runx2) by enhancing transcription factor binding at target promoters, undergoes acetylation that enables nucleosome binding and co-remodeling with SWI/SNF, shuttles between nucleus and cytoplasm (with cytoplasmic retention suppressing EMT), regulates 3D genome organization and CTCF clustering during senescence entry, acts as a cell-intrinsic epigenetic regulator of exhausted CD8+ T cell differentiation, and whose translation is controlled by NAT10-mediated ac4C mRNA modification via eEF2 recruitment."},"narrative":{"teleology":[{"year":1978,"claim":"Establishing that HMG proteins alter DNA topology resolved a fundamental question about whether non-histone chromosomal proteins could directly modify DNA structure, opening the field of HMG-mediated chromatin architecture.","evidence":"Topological winding number assay showing HMG1/2 reduce linking number of circular DNA","pmids":["628842"],"confidence":"High","gaps":["Mechanism of unwinding (intercalation vs. bending) not yet resolved","No domain dissection performed"]},{"year":1979,"claim":"Quantifying unwinding angles (~26° per HMG2 molecule) and demonstrating preferential single-strand binding established that HMG proteins locally denature base pairs rather than merely wrapping DNA.","evidence":"Melting absorption technique and competition unwinding experiments","pmids":["226939"],"confidence":"High","gaps":["Whether unwinding reflects physiological function or is an in vitro artifact was unresolved","Individual domain contributions unknown"]},{"year":1993,"claim":"Demonstrating that HMG1/2 bend DNA into circles as small as 59–66 bp and that box B suffices for bending established the paradigm that HMGB proteins function as architectural facilitators of nucleoprotein complex assembly.","evidence":"Ligase-mediated circularization assay, invertasome assembly assay with domain dissection","pmids":["8339930"],"confidence":"High","gaps":["Box A function remained unclear","In vivo relevance of DNA bending not yet shown"]},{"year":1994,"claim":"Discovery that HMG2 acts as a basal repressor of RNA Pol II transcription—blocking elongation after pre-initiation complex formation—and that TFIIH counteracts this repression revealed a dual transcriptional regulatory role.","evidence":"Reconstituted in vitro transcription with order-of-addition and antibody depletion experiments","pmids":["8007973","7797075"],"confidence":"High","gaps":["Whether repression and activation occur on the same promoters in vivo was unknown","Mechanism of TFIIH-mediated relief not fully defined"]},{"year":1999,"claim":"Identifying box B as the primary domain for DNA recognition and conformational change—with Phe-102 intercalation being critical—and showing that HMGB2 incorporates into RAG1/2-RSS complexes to enhance V(D)J recombination established two key paradigms: domain specialization and a direct role in adaptive immune receptor assembly.","evidence":"SPR kinetics, mutagenesis, supercoiling assays for domain function; co-IP, EMSA, circular permutation, and in vivo recombination assay for RAG interaction","pmids":["9888798","10490593","10390537"],"confidence":"High","gaps":["Structural basis of box B–DNA interaction at atomic resolution not determined","Relative contributions of HMGB1 vs HMGB2 in V(D)J recombination in vivo unclear"]},{"year":2001,"claim":"Hmgb2-knockout mice revealed essential, non-redundant roles: male infertility with spermatocyte degeneration demonstrated that despite co-expression with HMGB1, HMGB2 has tissue-specific functions in germ cell differentiation.","evidence":"Hmgb2−/− mouse phenotyping with histology and immunostaining","pmids":["11262228"],"confidence":"High","gaps":["Molecular targets of HMGB2 in spermatocytes not identified","Whether phenotype reflects chromatin architecture vs. transcription regulation unknown"]},{"year":2002,"claim":"Identification of HMGB2 as a SET complex component that provides DNA bending/looping activity and is specifically cleaved by granzyme A linked HMGB2 to the cytotoxic lymphocyte killing pathway and apoptotic DNA fragmentation.","evidence":"Co-immunoprecipitation, confocal colocalization at ER, in vitro granzyme A cleavage assay","pmids":["11909973"],"confidence":"High","gaps":["Whether granzyme A cleavage of HMGB2 is essential for target cell death in vivo not tested","Stoichiometry within the SET complex undefined"]},{"year":2009,"claim":"A burst of discoveries established HMGB2 as a transcriptional co-activator at specific promoters (GFI1B, topo IIα, Lef-1/β-catenin targets), showed acetylation enables nucleosome binding and SWI/SNF co-remodeling, and revealed essential roles in chondrocyte survival and cartilage homeostasis via Wnt signaling.","evidence":"ChIP at GFI1B promoter with differentiation assay; siRNA/reporter for topo IIα; EMSA/reporter/KO mouse for Lef-1; nucleosome binding/remodeling assays with acetylated HMGB2; Hmgb2−/− mouse osteoarthritis model","pmids":["19965638","19223331","19805379","19522541","19139395"],"confidence":"High","gaps":["Acetyltransferase(s) responsible for HMGB2 acetylation in vivo not identified","Whether nucleosome remodeling function operates at specific loci or genome-wide unknown","Direct structural basis for acetylation-dependent nucleosome recognition unresolved"]},{"year":2016,"claim":"ChIP-seq and Hi-C revealed that HMGB2 preferentially occupies SASP gene loci during senescence, acting as an anti-silencing boundary that prevents heterochromatin spreading; separately, HMGB2 was shown to drive myogenesis through IGF2BP2-mediated post-transcriptional regulation of Myf5.","evidence":"ChIP-seq/Hi-C with siRNA in senescent fibroblasts; shRNA knockdown with IGF2BP2 rescue and in vivo muscle injury model","pmids":["27799366","27672022"],"confidence":"High","gaps":["Whether HMGB2 directly recruits boundary factors or passively blocks heterochromatin unknown","Mechanism by which HMGB2 transcriptionally activates IGF2BP2 not defined"]},{"year":2018,"claim":"Nuclear depletion of HMGB2 was shown to be an early senescence event that triggers CTCF spatial clustering and 3D genome loop reorganization, establishing HMGB2 as a master regulator of genome topology during cellular aging; concurrently, cytoplasmic retention of HMGB2 by lnc-CRCMSL was found to suppress EMT by preventing nuclear HMGB2-OCT4 interaction.","evidence":"Hi-C, single-cell RNA-seq, HMGB2 knockdown/rescue across three cell types; RNA pulldown plus leptomycin B pharmacological validation","pmids":["29706538","30575817"],"confidence":"High","gaps":["Direct molecular mechanism by which HMGB2 prevents CTCF clustering not defined","Whether nucleocytoplasmic shuttling regulation differs across tissue types untested"]},{"year":2023,"claim":"Discovery that HMGB2 cell-intrinsically regulates exhausted CD8+ T cell progenitor (Tpex) differentiation during chronic infection and cancer—independently of canonical TCF-1/TOX—revealed a new immune-epigenetic function with therapeutic implications.","evidence":"Hmgb2−/− mouse with chronic LCMV and tumor models, single-cell RNA-seq, ATAC-seq","pmids":["37704621"],"confidence":"High","gaps":["Direct chromatin targets of HMGB2 in Tpex cells not mapped","Whether HMGB2 acts through CTCF reorganization in T cells as in senescence untested"]},{"year":2024,"claim":"Identification of NAT10-mediated ac4C modification on HMGB2 mRNA CDS that enhances translation via eEF2 recruitment established a novel epitranscriptomic layer controlling HMGB2 protein abundance.","evidence":"acRIP-seq, ribosome profiling, RNA pulldown/mass spectrometry, site-specific mutagenesis","pmids":["39030964"],"confidence":"High","gaps":["Whether ac4C-mediated translational control is tissue-specific unknown","Upstream signals regulating NAT10-dependent HMGB2 mRNA modification not identified"]},{"year":null,"claim":"Key unresolved questions include: (1) how HMGB2 mechanistically prevents CTCF clustering and heterochromatin spreading at the molecular level, (2) which acetyltransferases modify HMGB2 in vivo and how this is regulated, (3) whether HMGB2's genome-topology and transcriptional co-activator functions are separable, and (4) the structural basis for promoter-specific recruitment.","evidence":"","pmids":[],"confidence":"Low","gaps":["No high-resolution structure of HMGB2 bound to a nucleosome or promoter complex","No genome-wide binding data comparing HMGB2 occupancy across tissues and differentiation states","Functional redundancy with HMGB1 incompletely dissected"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,1,2,9,14]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[3,4,17,19,25,32]},{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[2,12,14]},{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[18]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[5,13,25,27]},{"term_id":"GO:0005694","term_label":"chromosome","supporting_discovery_ids":[13,25]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[12,35]},{"term_id":"GO:0005654","term_label":"nucleoplasm","supporting_discovery_ids":[5,27]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[3,4,17,19,25,32]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[18,25,27]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[7,8,36]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[6,12]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[11,19,26]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[16,20,29]}],"complexes":["SET complex","RAG1/RAG2-RSS complex","SRC-1/ER complex"],"partners":["RAG1","SET","LEF1","SRC1","ESR1","OCT4","CTCF","IGF2BP2"],"other_free_text":[]},"mechanistic_narrative":"HMGB2 is a non-histone chromatin architectural protein that bends and unwinds DNA through its tandem HMG box domains—box B being the principal domain for DNA recognition and conformational change—thereby facilitating assembly of diverse nucleoprotein complexes and modulating transcription [PMID:628842, PMID:9888798, PMID:8339930]. It acts as a transcriptional co-regulator by enhancing transcription factor binding at target promoters (Oct-1 at GFI1B, NF-Y at topo IIα, Lef-1/β-catenin at Wnt targets, C/EBPβ during adipogenesis, SRC-1/ER in endocrine-resistant breast cancer), and its acetylation enables nucleosome binding and cooperative chromatin remodeling with SWI/SNF [PMID:19965638, PMID:19805379, PMID:19223331, PMID:34215724, PMID:25284587, PMID:19522541]. During cellular senescence, HMGB2 prevents heterochromatin spreading into SASP gene loci and its nuclear depletion triggers CTCF spatial clustering and 3D genome reorganization; in CD8+ T cells it functions as a cell-intrinsic epigenetic regulator required for stem-like progenitor exhausted T cell maintenance during chronic infection and cancer [PMID:27799366, PMID:29706538, PMID:37704621]. Hmgb2-knockout mice exhibit reduced male fertility with spermatogenic defects, accelerated osteoarthritis with superficial-zone chondrocyte apoptosis, and impaired muscle regeneration, establishing essential tissue-specific roles in germ cell differentiation, cartilage homeostasis, and myogenesis [PMID:11262228, PMID:19139395, PMID:27672022]."},"prefetch_data":{"uniprot":{"accession":"P26583","full_name":"High mobility group protein B2","aliases":["High mobility group protein 2","HMG-2"],"length_aa":209,"mass_kda":24.0,"function":"Multifunctional protein with various roles in different cellular compartments. May act in a redox sensitive manner. In the nucleus is an abundant chromatin-associated non-histone protein involved in transcription, chromatin remodeling and V(D)J recombination and probably other processes. Binds DNA with a preference to non-canonical DNA structures such as single-stranded DNA. Can bent DNA and enhance DNA flexibility by looping thus providing a mechanism to promote activities on various gene promoters by enhancing transcription factor binding and/or bringing distant regulatory sequences into close proximity (PubMed:11909973, PubMed:18413230, PubMed:19522541, PubMed:19965638, PubMed:20123072, PubMed:7797075). Involved in V(D)J recombination by acting as a cofactor of the RAG complex: acts by stimulating cleavage and RAG protein binding at the 23 bp spacer of conserved recombination signal sequences (RSS) (By similarity). Proposed to be involved in the innate immune response to nucleic acids by acting as a promiscuous immunogenic DNA/RNA sensor which cooperates with subsequent discriminative sensing by specific pattern recognition receptors (By similarity). In the extracellular compartment acts as a chemokine. Promotes proliferation and migration of endothelial cells implicating AGER/RAGE (PubMed:19811285). Has antimicrobial activity in gastrointestinal epithelial tissues (PubMed:23877675). Involved in inflammatory response to antigenic stimulus coupled with pro-inflammatory activity (By similarity). Involved in modulation of neurogenesis probably by regulation of neural stem proliferation (By similarity). Involved in articular cartilage surface maintenance implicating LEF1 and the Wnt/beta-catenin pathway (By similarity)","subcellular_location":"Nucleus; Chromosome; Cytoplasm; Secreted","url":"https://www.uniprot.org/uniprotkb/P26583/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/HMGB2","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000164104","cell_line_id":"CID001755","localizations":[{"compartment":"nucleoplasm","grade":3},{"compartment":"chromatin","grade":2}],"interactors":[{"gene":"RPS19","stoichiometry":10.0},{"gene":"RPLP2","stoichiometry":10.0},{"gene":"RPL39P5;RPL39","stoichiometry":4.0},{"gene":"GNB2L1","stoichiometry":4.0},{"gene":"RPL8","stoichiometry":4.0},{"gene":"RPL10A","stoichiometry":4.0},{"gene":"RPS20","stoichiometry":4.0},{"gene":"RPL27","stoichiometry":4.0},{"gene":"RPS6","stoichiometry":4.0},{"gene":"RPS25","stoichiometry":4.0}],"url":"https://opencell.sf.czbiohub.org/target/CID001755","total_profiled":1310},"omim":[{"mim_id":"606009","title":"DOUBLE HOMEOBOX PROTEIN 4; DUX4","url":"https://www.omim.org/entry/606009"},{"mim_id":"602700","title":"E1A-BINDING PROTEIN, 300-KD; EP300","url":"https://www.omim.org/entry/602700"},{"mim_id":"601425","title":"TRANSCRIPTION ELONGATION FACTOR A, 1; TCEA1","url":"https://www.omim.org/entry/601425"},{"mim_id":"300193","title":"HIGH MOBILITY GROUP BOX 3; HMGB3","url":"https://www.omim.org/entry/300193"},{"mim_id":"163906","title":"HIGH MOBILITY GROUP BOX 2; HMGB2","url":"https://www.omim.org/entry/163906"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Nucleoli","reliability":"Additional"},{"location":"Principal piece","reliability":"Additional"},{"location":"Annulus","reliability":"Additional"}],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"bone marrow","ntpm":2214.7},{"tissue":"lymphoid tissue","ntpm":874.1}],"url":"https://www.proteinatlas.org/search/HMGB2"},"hgnc":{"alias_symbol":[],"prev_symbol":["HMG2"]},"alphafold":{"accession":"P26583","domains":[{"cath_id":"1.10.30.10","chopping":"14-76","consensus_level":"high","plddt":89.464,"start":14,"end":76},{"cath_id":"1.10.30.10","chopping":"100-170","consensus_level":"high","plddt":90.1,"start":100,"end":170}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P26583","model_url":"https://alphafold.ebi.ac.uk/files/AF-P26583-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P26583-F1-predicted_aligned_error_v6.png","plddt_mean":77.56},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=HMGB2","jax_strain_url":"https://www.jax.org/strain/search?query=HMGB2"},"sequence":{"accession":"P26583","fasta_url":"https://rest.uniprot.org/uniprotkb/P26583.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P26583/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P26583"}},"corpus_meta":[{"pmid":"8339930","id":"PMC_8339930","title":"The nonspecific DNA-binding and -bending proteins HMG1 and HMG2 promote the assembly of complex nucleoprotein structures.","date":"1993","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/8339930","citation_count":309,"is_preprint":false},{"pmid":"628842","id":"PMC_628842","title":"Nonhistone proteins HMG1 and HMG2 change the DNA helical structure.","date":"1978","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/628842","citation_count":222,"is_preprint":false},{"pmid":"25996293","id":"PMC_25996293","title":"miR-23b-3p regulates the chemoresistance of gastric cancer cells by targeting ATG12 and HMGB2.","date":"2015","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/25996293","citation_count":190,"is_preprint":false},{"pmid":"29706538","id":"PMC_29706538","title":"HMGB2 Loss upon Senescence Entry Disrupts Genomic Organization and Induces CTCF Clustering across Cell Types.","date":"2018","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/29706538","citation_count":174,"is_preprint":false},{"pmid":"11262228","id":"PMC_11262228","title":"Reduced fertility and spermatogenesis defects in mice lacking chromosomal protein Hmgb2.","date":"2001","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11262228","citation_count":172,"is_preprint":false},{"pmid":"11748232","id":"PMC_11748232","title":"HMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequence-specific transactivation from the human Bax gene promoter.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11748232","citation_count":164,"is_preprint":false},{"pmid":"27799366","id":"PMC_27799366","title":"HMGB2 orchestrates the chromatin landscape of senescence-associated secretory phenotype gene loci.","date":"2016","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/27799366","citation_count":137,"is_preprint":false},{"pmid":"7797075","id":"PMC_7797075","title":"Activation of the TFIID-TFIIA complex with HMG-2.","date":"1995","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/7797075","citation_count":131,"is_preprint":false},{"pmid":"11909973","id":"PMC_11909973","title":"HMG2 interacts with the nucleosome assembly protein SET and is a target of the cytotoxic T-lymphocyte protease granzyme A.","date":"2002","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11909973","citation_count":118,"is_preprint":false},{"pmid":"19139395","id":"PMC_19139395","title":"Aging-related loss of the chromatin protein HMGB2 in articular cartilage is linked to reduced cellularity and osteoarthritis.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19139395","citation_count":118,"is_preprint":false},{"pmid":"2583185","id":"PMC_2583185","title":"Tissue specificity of nucleo-cytoplasmic distribution of HMG1 and HMG2 proteins and their probable functions.","date":"1989","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2583185","citation_count":113,"is_preprint":false},{"pmid":"12925773","id":"PMC_12925773","title":"Association of chromatin proteins high mobility group box (HMGB) 1 and HMGB2 with mitotic chromosomes.","date":"2003","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/12925773","citation_count":110,"is_preprint":false},{"pmid":"10490593","id":"PMC_10490593","title":"The RAG1 homeodomain recruits HMG1 and HMG2 to facilitate recombination signal sequence binding and to enhance the intrinsic DNA-bending activity of RAG1-RAG2.","date":"1999","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10490593","citation_count":106,"is_preprint":false},{"pmid":"226939","id":"PMC_226939","title":"Nonhistone proteins HMG1 and HMG2 unwind DNA double helix.","date":"1979","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/226939","citation_count":94,"is_preprint":false},{"pmid":"25937287","id":"PMC_25937287","title":"Antisense RNA controls LRP1 Sense transcript expression through interaction with a chromatin-associated protein, HMGB2.","date":"2015","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/25937287","citation_count":87,"is_preprint":false},{"pmid":"29463261","id":"PMC_29463261","title":"HMGB2 is associated with malignancy and regulates Warburg effect by targeting LDHB and FBP1 in breast cancer.","date":"2018","source":"Cell communication and signaling : CCS","url":"https://pubmed.ncbi.nlm.nih.gov/29463261","citation_count":75,"is_preprint":false},{"pmid":"6458811","id":"PMC_6458811","title":"Loss of chromosomal high mobility group proteins HMG1 and HMG2 when mouse neuroblastoma and Friend erythroleukemia cells become committed to differentiation.","date":"1981","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/6458811","citation_count":71,"is_preprint":false},{"pmid":"19805379","id":"PMC_19805379","title":"Chromatin protein HMGB2 regulates articular cartilage surface maintenance via beta-catenin pathway.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19805379","citation_count":69,"is_preprint":false},{"pmid":"9010268","id":"PMC_9010268","title":"Novel autoantigens of perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) in ulcerative colitis: non-histone chromosomal proteins, HMG1 and HMG2.","date":"1997","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9010268","citation_count":67,"is_preprint":false},{"pmid":"9558172","id":"PMC_9558172","title":"Prevalence and characterization of novel pANCA, antibodies to the high mobility group non-histone chromosomal proteins HMG1 and HMG2, in systemic rheumatic diseases.","date":"1998","source":"The Journal of rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/9558172","citation_count":61,"is_preprint":false},{"pmid":"15833996","id":"PMC_15833996","title":"Dual binding modes for an HMG domain from human HMGB2 on DNA.","date":"2005","source":"Biophysical journal","url":"https://pubmed.ncbi.nlm.nih.gov/15833996","citation_count":61,"is_preprint":false},{"pmid":"7780305","id":"PMC_7780305","title":"Expression of the Arabidopsis HMG2 gene, encoding 3-hydroxy-3-methylglutaryl coenzyme A reductase, is restricted to meristematic and floral tissues.","date":"1995","source":"The Plant cell","url":"https://pubmed.ncbi.nlm.nih.gov/7780305","citation_count":61,"is_preprint":false},{"pmid":"2350545","id":"PMC_2350545","title":"Primary structure of non-histone chromosomal protein HMG2 revealed by the nucleotide sequence.","date":"1990","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2350545","citation_count":59,"is_preprint":false},{"pmid":"10390537","id":"PMC_10390537","title":"A dimer of the lymphoid protein RAG1 recognizes the recombination signal sequence and the complex stably incorporates the high mobility group protein HMG2.","date":"1999","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/10390537","citation_count":59,"is_preprint":false},{"pmid":"28396617","id":"PMC_28396617","title":"Long non-coding RNA MALAT1 drives gastric cancer progression by regulating HMGB2 modulating the miR-1297.","date":"2017","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/28396617","citation_count":57,"is_preprint":false},{"pmid":"37176041","id":"PMC_37176041","title":"Structure and Functions of HMGB2 Protein.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37176041","citation_count":56,"is_preprint":false},{"pmid":"8007973","id":"PMC_8007973","title":"Repression of basal transcription by HMG2 is counteracted by TFIIH-associated factors in an ATP-dependent process.","date":"1994","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8007973","citation_count":56,"is_preprint":false},{"pmid":"28069585","id":"PMC_28069585","title":"Expression of HMGB2 indicates worse survival of patients and is required for the maintenance of Warburg effect in pancreatic cancer.","date":"2017","source":"Acta biochimica et biophysica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/28069585","citation_count":52,"is_preprint":false},{"pmid":"17917299","id":"PMC_17917299","title":"Chemical phenotypes of the hmg1 and hmg2 mutants of Arabidopsis demonstrate the in-planta role of HMG-CoA reductase in triterpene biosynthesis.","date":"2007","source":"Chemical & pharmaceutical bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/17917299","citation_count":50,"is_preprint":false},{"pmid":"10323891","id":"PMC_10323891","title":"High mobility group (HMG) non-histone chromosomal proteins HMG1 and HMG2 are significant target antigens of perinuclear anti-neutrophil cytoplasmic antibodies in autoimmune hepatitis.","date":"1999","source":"Gut","url":"https://pubmed.ncbi.nlm.nih.gov/10323891","citation_count":48,"is_preprint":false},{"pmid":"30575817","id":"PMC_30575817","title":"Long noncoding RNA CRCMSL suppresses tumor invasive and metastasis in colorectal carcinoma through nucleocytoplasmic shuttling of HMGB2.","date":"2018","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/30575817","citation_count":47,"is_preprint":false},{"pmid":"30657566","id":"PMC_30657566","title":"The lncRNA HOXA11-AS promotes glioma cell growth and metastasis by targeting miR-130a-5p/HMGB2.","date":"2019","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30657566","citation_count":46,"is_preprint":false},{"pmid":"2277118","id":"PMC_2277118","title":"Efficient large-scale purification of non-histone chromosomal proteins HMG1 and HMG2 by using Polybuffer-exchanger PBE94.","date":"1990","source":"Journal of chromatography","url":"https://pubmed.ncbi.nlm.nih.gov/2277118","citation_count":46,"is_preprint":false},{"pmid":"21890638","id":"PMC_21890638","title":"Expression patterns and function of chromatin protein HMGB2 during mesenchymal stem cell differentiation.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21890638","citation_count":45,"is_preprint":false},{"pmid":"20550581","id":"PMC_20550581","title":"Observations on squalene accumulation in Saccharomyces cerevisiae due to the manipulation of HMG2 and ERG6.","date":"2010","source":"FEMS yeast research","url":"https://pubmed.ncbi.nlm.nih.gov/20550581","citation_count":44,"is_preprint":false},{"pmid":"23259547","id":"PMC_23259547","title":"Positive genetic interactors of HMG2 identify a new set of genetic perturbations for improving sesquiterpene production in Saccharomyces cerevisiae.","date":"2012","source":"Microbial cell factories","url":"https://pubmed.ncbi.nlm.nih.gov/23259547","citation_count":44,"is_preprint":false},{"pmid":"30699189","id":"PMC_30699189","title":"Oncogenic KSHV-encoded interferon regulatory factor upregulates HMGB2 and CMPK1 expression to promote cell invasion by disrupting a complex lncRNA-OIP5-AS1/miR-218-5p network.","date":"2019","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/30699189","citation_count":43,"is_preprint":false},{"pmid":"19223331","id":"PMC_19223331","title":"HMGB1 and HMGB2 proteins up-regulate cellular expression of human topoisomerase IIalpha.","date":"2009","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/19223331","citation_count":41,"is_preprint":false},{"pmid":"23495099","id":"PMC_23495099","title":"Oct4 interaction with Hmgb2 regulates Akt signaling and pluripotency.","date":"2013","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/23495099","citation_count":40,"is_preprint":false},{"pmid":"19522541","id":"PMC_19522541","title":"Nucleosome binding properties and Co-remodeling activities of native and in vivo acetylated HMGB-1 and HMGB-2 proteins.","date":"2009","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19522541","citation_count":38,"is_preprint":false},{"pmid":"28183701","id":"PMC_28183701","title":"Association of Serum HMGB2 Levels With In-Stent Restenosis: HMGB2 Promotes Neointimal Hyperplasia in Mice With Femoral Artery Injury and Proliferation and Migration of VSMCs.","date":"2017","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/28183701","citation_count":38,"is_preprint":false},{"pmid":"1551873","id":"PMC_1551873","title":"Structure of a gene coding for human HMG2 protein.","date":"1992","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1551873","citation_count":37,"is_preprint":false},{"pmid":"28011583","id":"PMC_28011583","title":"Association of serum HMGB2 level with MACE at 1 mo of myocardial infarction: Aggravation of myocardial ischemic injury in rats by HMGB2 via ROS.","date":"2016","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/28011583","citation_count":37,"is_preprint":false},{"pmid":"9784391","id":"PMC_9784391","title":"Identification of the nuclear factor HMG2 as an activator for DFF nuclease activity.","date":"1998","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/9784391","citation_count":37,"is_preprint":false},{"pmid":"9888798","id":"PMC_9888798","title":"Differences in DNA recognition and conformational change activity between boxes A and B in HMG2 protein.","date":"1999","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9888798","citation_count":37,"is_preprint":false},{"pmid":"25284587","id":"PMC_25284587","title":"Genomic interaction between ER and HMGB2 identifies DDX18 as a novel driver of endocrine resistance in breast cancer cells.","date":"2014","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/25284587","citation_count":35,"is_preprint":false},{"pmid":"37704621","id":"PMC_37704621","title":"HMGB2 regulates the differentiation and stemness of exhausted CD8+ T cells during chronic viral infection and cancer.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/37704621","citation_count":34,"is_preprint":false},{"pmid":"39030964","id":"PMC_39030964","title":"Targeting N4-acetylcytidine suppresses hepatocellular carcinoma progression by repressing eEF2-mediated HMGB2 mRNA translation.","date":"2024","source":"Cancer communications (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/39030964","citation_count":34,"is_preprint":false},{"pmid":"913411","id":"PMC_913411","title":"Interaction of non-histone chromosomal proteins HMG1 and HMG2 with DNA.","date":"1977","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/913411","citation_count":34,"is_preprint":false},{"pmid":"20940346","id":"PMC_20940346","title":"Nucleocytoplasmic distribution of the Arabidopsis chromatin-associated HMGB2/3 and HMGB4 proteins.","date":"2010","source":"Plant physiology","url":"https://pubmed.ncbi.nlm.nih.gov/20940346","citation_count":34,"is_preprint":false},{"pmid":"32391592","id":"PMC_32391592","title":"MicroRNA-127-5p impairs function of granulosa cells via HMGB2 gene in premature ovarian insufficiency.","date":"2020","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/32391592","citation_count":34,"is_preprint":false},{"pmid":"23255232","id":"PMC_23255232","title":"High-mobility group box 2 (HMGB2) modulates radioresponse and is downregulated by p53 in colorectal cancer cell.","date":"2012","source":"Cancer biology & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/23255232","citation_count":34,"is_preprint":false},{"pmid":"19965638","id":"PMC_19965638","title":"High-mobility group protein HMGB2 regulates human erythroid differentiation through trans-activation of GFI1B transcription.","date":"2009","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/19965638","citation_count":32,"is_preprint":false},{"pmid":"21628456","id":"PMC_21628456","title":"The sterol-sensing domain (SSD) directly mediates signal-regulated endoplasmic reticulum-associated degradation (ERAD) of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase isozyme Hmg2.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21628456","citation_count":32,"is_preprint":false},{"pmid":"25327479","id":"PMC_25327479","title":"Silencing of high-mobility group box 2 (HMGB2) modulates cisplatin and 5-fluorouracil sensitivity in head and neck squamous cell carcinoma.","date":"2015","source":"Proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/25327479","citation_count":31,"is_preprint":false},{"pmid":"7758147","id":"PMC_7758147","title":"Differential expression of nuclear HMG1, HMG2 proteins and H1(zero) histone in various blood cells.","date":"1995","source":"Cell biochemistry and function","url":"https://pubmed.ncbi.nlm.nih.gov/7758147","citation_count":30,"is_preprint":false},{"pmid":"6458621","id":"PMC_6458621","title":"Comparative studies on microinjected high-mobility-group chromosomal proteins, HMG1 and HMG2.","date":"1981","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/6458621","citation_count":30,"is_preprint":false},{"pmid":"33658008","id":"PMC_33658008","title":"microRNA-130a-5p suppresses myocardial ischemia reperfusion injury by downregulating the HMGB2/NF-κB axis.","date":"2021","source":"BMC cardiovascular disorders","url":"https://pubmed.ncbi.nlm.nih.gov/33658008","citation_count":30,"is_preprint":false},{"pmid":"27672022","id":"PMC_27672022","title":"HMGB2 regulates satellite-cell-mediated skeletal muscle regeneration through IGF2BP2.","date":"2016","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/27672022","citation_count":29,"is_preprint":false},{"pmid":"16098203","id":"PMC_16098203","title":"Recombinant derivatives of the human high-mobility group protein HMGB2 mediate efficient nonviral gene delivery.","date":"2005","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/16098203","citation_count":29,"is_preprint":false},{"pmid":"23756189","id":"PMC_23756189","title":"Characterizations of two grass carp Ctenopharyngodon idella HMGB2 genes and potential roles in innate immunity.","date":"2013","source":"Developmental and comparative immunology","url":"https://pubmed.ncbi.nlm.nih.gov/23756189","citation_count":29,"is_preprint":false},{"pmid":"24391977","id":"PMC_24391977","title":"Aberrant neural stem cell proliferation and increased adult neurogenesis in mice lacking chromatin protein HMGB2.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24391977","citation_count":29,"is_preprint":false},{"pmid":"28771884","id":"PMC_28771884","title":"HMGB2 expression is associated with transition from a quiescent to an activated state of adult neural stem cells.","date":"2017","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/28771884","citation_count":29,"is_preprint":false},{"pmid":"35091064","id":"PMC_35091064","title":"HMGB2 causes photoreceptor death via down-regulating Nrf2/HO-1 and up-regulating NF-κB/NLRP3 signaling pathways in light-induced retinal degeneration model.","date":"2022","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35091064","citation_count":28,"is_preprint":false},{"pmid":"11041984","id":"PMC_11041984","title":"High affinity binding of proteins HMG1 and HMG2 to semicatenated DNA loops.","date":"2000","source":"BMC molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11041984","citation_count":28,"is_preprint":false},{"pmid":"9166769","id":"PMC_9166769","title":"Nuclear accumulation of HMG2 protein is mediated by basic regions interspaced with a long DNA-binding sequence, and retention within the nucleus requires the acidic carboxyl terminus.","date":"1997","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9166769","citation_count":28,"is_preprint":false},{"pmid":"9617797","id":"PMC_9617797","title":"Abundance of mRNAs encoding HMG1/HMG2 class high-mobility-group DNA-binding proteins are differentially regulated in cotyledons of Pharbitis nil.","date":"1998","source":"Plant molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9617797","citation_count":27,"is_preprint":false},{"pmid":"7763232","id":"PMC_7763232","title":"Repression of cell cycle progression by antisense HMG2 RNA.","date":"1995","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/7763232","citation_count":26,"is_preprint":false},{"pmid":"6235858","id":"PMC_6235858","title":"Isolation of high-mobility-group proteins HMG1 and HMG2 in non denaturing conditions and comparison of their properties with those of acid-extracted proteins.","date":"1984","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/6235858","citation_count":26,"is_preprint":false},{"pmid":"18400754","id":"PMC_18400754","title":"High mobility group protein HMGB2 is a critical regulator of plasmodium oocyst development.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18400754","citation_count":26,"is_preprint":false},{"pmid":"30119172","id":"PMC_30119172","title":"Involvement of JNK1/2-NF-κBp65 in the regulation of HMGB2 in myocardial ischemia/reperfusion-induced apoptosis in human AC16 cardiomyocytes.","date":"2018","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/30119172","citation_count":26,"is_preprint":false},{"pmid":"31219186","id":"PMC_31219186","title":"MicroRNA-329 upregulation impairs the HMGB2/β-catenin pathway and regulates cell biological behaviors in melanoma.","date":"2019","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/31219186","citation_count":26,"is_preprint":false},{"pmid":"34215724","id":"PMC_34215724","title":"HMGB2 orchestrates mitotic clonal expansion by binding to the promoter of C/EBPβ to facilitate adipogenesis.","date":"2021","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/34215724","citation_count":26,"is_preprint":false},{"pmid":"33707625","id":"PMC_33707625","title":"The LncRNA RP11-301G19.1/miR-582-5p/HMGB2 axis modulates the proliferation and apoptosis of multiple myeloma cancer cells via the PI3K/AKT signalling pathway.","date":"2021","source":"Cancer gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/33707625","citation_count":25,"is_preprint":false},{"pmid":"20036050","id":"PMC_20036050","title":"HMGB2 stabilizes p53 by interfering with E6/E6AP-mediated p53 degradation in human papillomavirus-positive HeLa cells.","date":"2009","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/20036050","citation_count":25,"is_preprint":false},{"pmid":"31103821","id":"PMC_31103821","title":"Involvement of microRNA-23b-5p in the promotion of cardiac hypertrophy and dysfunction via the HMGB2 signaling pathway.","date":"2019","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/31103821","citation_count":24,"is_preprint":false},{"pmid":"23306196","id":"PMC_23306196","title":"Insulin-induced gene protein (INSIG)-dependent sterol regulation of Hmg2 endoplasmic reticulum-associated degradation (ERAD) in yeast.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23306196","citation_count":23,"is_preprint":false},{"pmid":"31171637","id":"PMC_31171637","title":"Latexin regulation by HMGB2 is required for hematopoietic stem cell maintenance.","date":"2019","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/31171637","citation_count":23,"is_preprint":false},{"pmid":"2465778","id":"PMC_2465778","title":"Nonhistone proteins HMG1 and HMG2 suppress the nucleosome assembly at physiological ionic strength.","date":"1989","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/2465778","citation_count":23,"is_preprint":false},{"pmid":"12591612","id":"PMC_12591612","title":"Molecular characterization of three 3-hydroxy-3-methylglutaryl-CoA reductase genes including pathogen-induced Hmg2 from pepper (Capsicum annuum).","date":"2003","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/12591612","citation_count":23,"is_preprint":false},{"pmid":"38148870","id":"PMC_38148870","title":"HMGB2 Deficiency Mitigates Abdominal Aortic Aneurysm by Suppressing Ang-II-Caused Ferroptosis and Inflammation via NF-κβ Pathway.","date":"2023","source":"Mediators of inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/38148870","citation_count":22,"is_preprint":false},{"pmid":"30886640","id":"PMC_30886640","title":"6-Gingerol Attenuates Ischemia-Reperfusion-Induced Cell Apoptosis in Human AC16 Cardiomyocytes through HMGB2-JNK1/2-NF-κB Pathway.","date":"2019","source":"Evidence-based complementary and alternative medicine : eCAM","url":"https://pubmed.ncbi.nlm.nih.gov/30886640","citation_count":21,"is_preprint":false},{"pmid":"4084291","id":"PMC_4084291","title":"Differential binding of chromosomal proteins HMG1 and HMG2 to superhelical DNA.","date":"1985","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/4084291","citation_count":21,"is_preprint":false},{"pmid":"36834988","id":"PMC_36834988","title":"Structural Characteristics of High-Mobility Group Proteins HMGB1 and HMGB2 and Their Interaction with DNA.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36834988","citation_count":21,"is_preprint":false},{"pmid":"10501034","id":"PMC_10501034","title":"Hmg-coA reductase gene family in cotton (Gossypium hirsutum L.): unique structural features and differential expression of hmg2 potentially associated with synthesis of specific isoprenoids in developing embryos.","date":"1999","source":"Plant & cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/10501034","citation_count":21,"is_preprint":false},{"pmid":"28851665","id":"PMC_28851665","title":"Downregulation of miR-130a promotes cell growth and epithelial to mesenchymal transition by activating HMGB2 in glioma.","date":"2017","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/28851665","citation_count":20,"is_preprint":false},{"pmid":"34699756","id":"PMC_34699756","title":"LncRNA SNHG16 accelerates atherosclerosis and promotes ox-LDL-induced VSMC growth via the miRNA-22-3p/HMGB2 axis.","date":"2021","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/34699756","citation_count":20,"is_preprint":false},{"pmid":"32982307","id":"PMC_32982307","title":"Long Noncoding RNA PART1 Promotes Hepatocellular Carcinoma Progression via Targeting miR-590-3p/HMGB2 Axis.","date":"2020","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/32982307","citation_count":20,"is_preprint":false},{"pmid":"6221763","id":"PMC_6221763","title":"Comparisons of the structures of the chromosomal high mobility group proteins HMG1 and HMG2 prepared under conditions of neutral and acidic pH.","date":"1983","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/6221763","citation_count":20,"is_preprint":false},{"pmid":"22644337","id":"PMC_22644337","title":"Anti-high mobility group box 1 and box 2 non-histone chromosomal proteins (HMGB1/HMGB2) antibodies and anti-Saccharomyces cerevisiae antibodies (ASCA): accuracy in differentially diagnosing UC and CD and correlation with inflammatory bowel disease phenotype.","date":"2012","source":"Journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/22644337","citation_count":20,"is_preprint":false},{"pmid":"29651745","id":"PMC_29651745","title":"Correlations between age, functional status, and the senescence-associated proteins HMGB2 and p16INK4a.","date":"2018","source":"GeroScience","url":"https://pubmed.ncbi.nlm.nih.gov/29651745","citation_count":19,"is_preprint":false},{"pmid":"3816775","id":"PMC_3816775","title":"Interaction of non-histone proteins HMG1 and HMG2 with core histones in nucleosomes and core particles revealed by chemical cross-linking.","date":"1987","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/3816775","citation_count":19,"is_preprint":false},{"pmid":"8679707","id":"PMC_8679707","title":"Intracellular distribution of HMG1, HMG2 and UBF change following treatment with cisplatin.","date":"1996","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/8679707","citation_count":19,"is_preprint":false},{"pmid":"31661640","id":"PMC_31661640","title":"HMGB2 is a negative regulator of telomerase activity in human embryonic stem and progenitor cells.","date":"2019","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/31661640","citation_count":18,"is_preprint":false},{"pmid":"30487376","id":"PMC_30487376","title":"Loss of Endogenous HMGB2 Promotes Cardiac Dysfunction and Pressure Overload-Induced Heart Failure in Mice.","date":"2018","source":"Circulation journal : official journal of the Japanese Circulation Society","url":"https://pubmed.ncbi.nlm.nih.gov/30487376","citation_count":18,"is_preprint":false},{"pmid":"8975778","id":"PMC_8975778","title":"Differential binding of HMG1, HMG2, and a single HMG box to cisplatin-damaged DNA.","date":"1996","source":"Toxicology and applied pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/8975778","citation_count":18,"is_preprint":false},{"pmid":"35831365","id":"PMC_35831365","title":"Spatiotemporal expression of HMGB2 regulates cell proliferation and hepatocyte size during liver regeneration.","date":"2022","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/35831365","citation_count":18,"is_preprint":false},{"pmid":"29942000","id":"PMC_29942000","title":"HMGB2 is a novel adipogenic factor that regulates ectopic fat infiltration in skeletal muscles.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29942000","citation_count":18,"is_preprint":false},{"pmid":"37930124","id":"PMC_37930124","title":"HMGB2 is a potential diagnostic marker and therapeutic target for liver fibrosis and cirrhosis.","date":"2023","source":"Hepatology communications","url":"https://pubmed.ncbi.nlm.nih.gov/37930124","citation_count":17,"is_preprint":false},{"pmid":"29050221","id":"PMC_29050221","title":"PDGFRA, HSD17B4 and HMGB2 are potential therapeutic targets in polycystic ovarian syndrome and breast cancer.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29050221","citation_count":16,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48905,"output_tokens":8771,"usd":0.13914},"stage2":{"model":"claude-opus-4-6","input_tokens":12719,"output_tokens":3625,"usd":0.23133},"total_usd":0.37047,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1978,\n      \"finding\": \"HMG1 and HMG2 reduce the linking number of circular DNA when present during covalent closure, demonstrating they can unwind the DNA double helix or induce supercoiling.\",\n      \"method\": \"Topological winding number assay with circular DNA\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct biochemical assay, foundational finding replicated in subsequent work\",\n      \"pmids\": [\"628842\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1979,\n      \"finding\": \"HMG1 and HMG2 unwind the DNA double helix by local denaturation of base pairs; net unwinding angles measured at 22° and 26° per molecule for HMG1 and HMG2 respectively; HMG1 has higher affinity for single-stranded vs. double-stranded DNA.\",\n      \"method\": \"Melting absorption technique, competition unwinding experiments\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — quantitative in vitro biochemical assay\",\n      \"pmids\": [\"226939\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"HMG1 and HMG2 promote assembly of complex nucleoprotein structures by bending DNA extremely efficiently, forming circles as small as 59–66 bp; HMG box B domain of HMG1 is sufficient for DNA bending and invertasome assembly; they can substitute for the prokaryotic HU protein in Hin-mediated site-specific DNA inversion.\",\n      \"method\": \"Invertasome assembly assay, ligase-mediated circularization assay, partial proteolytic digestion domain analysis\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal in vitro assays with domain dissection, highly cited foundational paper\",\n      \"pmids\": [\"8339930\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"HMG2 acts as a basal repressor of class II gene transcription by inhibiting transcription after assembly of a TBP-TFIIA-promoter complex but before formation of the fourth phosphodiester bond by RNA Pol II; a TFIIH-associated factor counteracts this repression in an ATP-dependent manner.\",\n      \"method\": \"In vitro transcription reconstitution, order-of-addition experiments, antibody depletion, ATP analog inhibition\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro transcription system with multiple mechanistic controls\",\n      \"pmids\": [\"8007973\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"HMG-2 was identified as a factor necessary for transcriptional activation in a defined in vitro RNA Pol II system; activation requires TFIIA and TAFs within TFIID; HMG-2 stabilizes an activated conformation of the TFIID-TFIIA-promoter complex; TFIIB dissociates more slowly from the activated preinitiation complex.\",\n      \"method\": \"In vitro transcription with purified factors, TFIIB titration, preinitiation complex analysis\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted defined in vitro transcription system\",\n      \"pmids\": [\"7797075\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Nuclear accumulation of HMG2 is mediated by basic regions interspaced with the HMG1/2 box DNA-binding sequence acting as a novel nuclear localization signal; retention within the nucleus requires the acidic carboxyl terminus, demonstrated by interspecies heterokaryon assay.\",\n      \"method\": \"HMG2-β-galactosidase fusion protein expression in COS-7 cells, deletion analysis, interspecies heterokaryon assay\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — deletion analysis in living cells with heterokaryon functional validation\",\n      \"pmids\": [\"9166769\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"HMG2 enhances the nuclease activity of DFF40/CAD during apoptosis, suggesting HMG proteins augment DNA fragmentation through changes in chromosome structure.\",\n      \"method\": \"Biochemical identification and in vitro nuclease activity assay with bacterially expressed HMG2\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro reconstitution assay, single lab single method\",\n      \"pmids\": [\"9784391\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The RAG1 homeodomain directly interacts with both HMG boxes of HMG1 and HMG2; this interaction facilitates RAG1/RAG2 binding to the recombination signal sequence, mainly by promoting high-affinity binding to the nonamer motif; HMG1/2 significantly enhance binding and bending of the 23RSS; transient HMG1/2 overexpression increases V(D)J recombination in vivo.\",\n      \"method\": \"Co-immunoprecipitation/direct interaction assay, electrophoretic mobility shift assay, circular permutation assay, transfection experiment\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal binding assays, in vivo validation, multiple orthogonal methods\",\n      \"pmids\": [\"10490593\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"A dimer of RAG1 stably incorporates HMG2 into the RAG1-RSS complex; HMG2 can increase the affinity of RAG1 for the RSS in the absence of RAG2.\",\n      \"method\": \"Electrophoretic mobility shift assay, recombinant protein expression, zinc analysis\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct biochemical binding assays, single lab\",\n      \"pmids\": [\"10390537\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"HMG2 box B is the main domain for DNA recognition and conformational changes (preferential binding to negatively supercoiled DNA, DNA unwinding); box A does not possess these activities alone; Phe-102 in box B intercalates into the base stack whereas Ala-16 in box A cannot.\",\n      \"method\": \"Gel retardation, DNA supercoiling assay, surface plasmon resonance (SPR) binding kinetics, computer modeling, recombinant peptide expression\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal in vitro assays with mutagenesis/domain dissection and structural modeling\",\n      \"pmids\": [\"9888798\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"HMGB1 physically interacts with p73α and p73β (both splice variants); both HMG box domains A and B of HMGB1 interact with p73α; HMGB1 enhances binding of p73 to specific cognate DNA sites; endogenous HMGB1 and HMGB2 inhibit p73α/β- and p53-dependent transactivation from the Bax gene promoter in a cell- and promoter-specific manner.\",\n      \"method\": \"Pull-down assay, gel-shift assay, transient transfection with antisense strategy, reporter gene assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal pull-down plus functional transcription assays, multiple cell lines\",\n      \"pmids\": [\"11748232\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Male Hmgb2-/- mice have reduced fertility with Sertoli and germ cell degeneration in seminiferous tubules and immotile spermatozoa; HMGB2 is expressed at very high levels in primary spermatocytes but barely detectable in spermatogonia and elongated spermatids, indicating a specialized role in germ cell differentiation.\",\n      \"method\": \"Knockout mouse (Hmgb2-/-) phenotypic analysis, histology, immunostaining, expression analysis\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic knockout with defined cellular phenotype, replicated findings\",\n      \"pmids\": [\"11262228\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"HMG2 is a component of the SET complex (endoplasmic reticulum-associated ~270-420 kDa complex containing SET, pp32, and APE); HMG2 coprecipitates with SET; cytoplasmic HMG2 colocalizes with SET at the ER; HMG2 provides the DNA bending and looping activities of the SET complex; HMG2 (but not HMG1) is a substrate of granzyme A, which cleaves after Lys65 in HMG box A, destroying DNA binding and bending functions.\",\n      \"method\": \"Co-immunoprecipitation, confocal microscopy colocalization, in vitro granzyme A cleavage assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP, colocalization imaging, biochemical cleavage assay with functional consequence\",\n      \"pmids\": [\"11909973\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"HMGB1 and HMGB2 are present in two forms in mitotic cells—free and associated with condensed chromatin—that rapidly exchange; for HMGB2, two sites encompassing HMG-box A and B are responsible for binding to mitotic chromosomes; this interaction is rapidly inactivated by cell permeabilization or chemical fixation.\",\n      \"method\": \"Live-cell imaging with GFP/DsRed-tagged proteins, fluorescence recovery after photobleaching (FRAP)\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — live-cell imaging with domain mapping, multiple fluorescent tags\",\n      \"pmids\": [\"12925773\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Isolated HMG box A from HMGB2 binds DNA in two modes: a flexible hinge mode at low protein concentrations (inducing average DNA bend of 114° at 50 mM Na+ or 87° at 100 mM Na+ and increasing DNA contour length) and a cooperative filament mode at higher concentrations.\",\n      \"method\": \"Optical tweezers single-molecule DNA stretching assay\",\n      \"journal\": \"Biophysical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — single-molecule biophysical measurement with quantitative parameters\",\n      \"pmids\": [\"15833996\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"HMGB2 is uniquely expressed in the superficial zone (SZ) of articular cartilage; aging-related loss of HMGB2 leads to increased chondrocyte apoptosis and earlier onset of more severe osteoarthritis in Hmgb2-/- mice; HMGB2 supports chondrocyte survival.\",\n      \"method\": \"Hmgb2-/- knockout mouse analysis, immunohistochemistry, in vitro apoptosis induction assay, histological scoring\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined cellular phenotype (apoptosis) and in vitro validation\",\n      \"pmids\": [\"19139395\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"HMGB2 enhances binding of Lef-1 to its target sequence and potentiates transcriptional activation of the Lef-1/β-catenin complex; the HMG domain of HMGB2 is required for interaction with Lef-1; HMGB2 and Wnt/β-catenin signaling co-localize specifically in the superficial zone of articular cartilage; conditional deletion of β-catenin in chondrocytes induces apoptosis.\",\n      \"method\": \"Luciferase reporter assay, electrophoretic mobility shift assay, immunofluorescence co-localization, conditional knockout mouse\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods establishing direct protein-protein interaction and functional transcriptional consequence\",\n      \"pmids\": [\"19805379\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"HMGB1 and HMGB2 up-regulate cellular expression of topoisomerase IIα; HMGB2 modulates binding of transcription factor NF-Y to the topo IIα promoter; HMGB1 DNA-bending activity is required for topo IIα promoter activation; this activation is inhibited by pRb.\",\n      \"method\": \"Knockdown of HMGB1/2 (siRNA), reporter assay, RT-PCR, Western blot, ChIP\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — knockdown with defined molecular phenotype, promoter analysis, multiple cell lines\",\n      \"pmids\": [\"19223331\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Acetylated forms of HMGB1 and HMGB2 acquire the ability to bind core nucleosomal particles (a property absent in non-acetylated proteins); acetylated HMGB1/2 show stronger binding to linker DNA-containing nucleosomes and higher co-remodeling activity with SWI/SNF and RSC; acetylation enhances SWI/SNF binding to the nucleosome without affecting its ATPase activity.\",\n      \"method\": \"Nucleosome binding assay, SWI/SNF/RSC-dependent nucleosome mobilization assay, ATPase activity measurement\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with post-translational modification functional consequence\",\n      \"pmids\": [\"19522541\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"HMGB2 regulates erythroid differentiation by binding to the GFI1B promoter in vivo and up-regulating its trans-activation by enhancing binding of Oct-1 and, to a lesser extent, GATA-1 and NF-Y; HMGB2 knockdown in hematopoietic progenitors leads to decreased Gfi-1B expression and impaired erythroid differentiation.\",\n      \"method\": \"ChIP (in vivo promoter binding), electrophoretic mobility shift assay, shRNA knockdown, differentiation assay\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP plus functional EMSA and loss-of-function differentiation phenotype\",\n      \"pmids\": [\"19965638\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"HMGB2 suppresses chondrogenic differentiation of mesenchymal stem cells; HMGB2 negatively regulates the stimulatory effect of Wnt/β-catenin signaling on the Runx2 proximal promoter; loss of HMGB2 accelerates osteogenesis and chondrogenic hypertrophy (enhanced Col10a1 and Runx2 expression) in MSC.\",\n      \"method\": \"Lentiviral HMGB2 transduction, Hmgb2-/- mouse MSC differentiation assays, reporter assay for Runx2 promoter\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — gain- and loss-of-function with defined molecular promoter mechanism\",\n      \"pmids\": [\"21890638\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"HMGB2 knockdown sensitizes colorectal cancer cells to ionizing radiation by increasing DNA damage and impairing DNA damage repair; p53 directly down-regulates HMGB2 promoter activity (confirmed by luciferase reporter and Nutlin-3/Tet-On p53 induction); radiation downregulates HMGB2 in TP53-intact but not TP53-mutant cells.\",\n      \"method\": \"shRNA knockdown, clonogenic assay, DNA damage markers, luciferase reporter assay, Nutlin-3 treatment, Tet-On p53 induction\",\n      \"journal\": \"Cancer biology & therapy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods linking p53, HMGB2 promoter regulation, and DNA repair function\",\n      \"pmids\": [\"23255232\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Oct4 post-translational modifications (phosphorylation and sumoylation) regulate its interaction with Hmgb2 and the SET complex; this promotes Akt activation and preserves H3K27me3 modifications in daughter progeny to maintain pluripotency in murine embryonic stem cells.\",\n      \"method\": \"Co-immunoprecipitation, phosphorylation mutant analysis, Akt activity assays, chromatin immunoprecipitation (H3K27me3)\",\n      \"journal\": \"Stem cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — co-IP with functional epistasis, single lab\",\n      \"pmids\": [\"23495099\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"HMGB2 interacts with SRC-1 and the oestrogen receptor (ER) in the endocrine-resistant setting; HMGB2/SRC-1/ER complex is enriched at promoter regions of target genes including the RNA helicase DDX18; modulation of DDX18 directly affects growth of tamoxifen-resistant cells.\",\n      \"method\": \"ChIP-seq (HMGB2), co-immunoprecipitation, gene expression integration, siRNA knockdown\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-seq plus co-IP and functional downstream target validation\",\n      \"pmids\": [\"25284587\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Lrp1-AS (antisense lncRNA) directly binds to HMGB2 and inhibits its activity to enhance Srebp1a-dependent transcription of Lrp1; short oligonucleotides targeting Lrp1-AS inhibit the lncRNA-HMGB2 interaction and increase Lrp1 expression.\",\n      \"method\": \"RNA-protein binding assay, co-immunoprecipitation, reporter assay, oligonucleotide targeting\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct RNA-protein interaction demonstrated with functional transcriptional consequence\",\n      \"pmids\": [\"25937287\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"HMGB2 preferentially localizes to SASP gene loci during senescence; loss of HMGB2 allows repressive heterochromatin to spread into SASP gene loci, incorporating them into SAHF and blunting SASP gene expression; HMGB2 acts as a master regulator of SASP by preventing heterochromatin spreading.\",\n      \"method\": \"ChIP-seq, siRNA knockdown, Hi-C, immunofluorescence, gene expression analysis\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-seq with functional loss-of-function showing chromatin and transcriptional consequences\",\n      \"pmids\": [\"27799366\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"HMGB2 is an essential nuclear transcriptional co-regulator in myogenesis; HMGB2 promotes Myf5 and cyclin A2 protein levels (not mRNA) by inducing IGF2BP2, an RNA-binding protein that enhances Myf5 mRNA translation and cyclin A2 mRNA stabilization; HMGB2 depletion in vivo reduces satellite cells and impairs muscle repair.\",\n      \"method\": \"siRNA/shRNA knockdown, overexpression, Western blot, RT-PCR, rescue experiment with IGF2BP2, in vivo muscle injury model\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis rescue experiment, in vivo knockout phenotype, defined molecular mechanism\",\n      \"pmids\": [\"27672022\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Nuclear depletion of HMGB2 occurs early on the path to senescence and coincides with dramatic spatial clustering of CTCF; HMGB2 knockdown is sufficient to induce senescence-associated CTCF clustering and loop reshuffling; ectopic HMGB2 expression rescues these effects.\",\n      \"method\": \"Hi-C, single-cell transcriptomics, imaging, in silico modeling, HMGB2 knockdown and rescue experiments across three cell types\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal genome-wide methods, rescue experiments, three cell types\",\n      \"pmids\": [\"29706538\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"HMGB2 stabilizes p53 in HPV-positive HeLa cells by interfering with E6/E6AP-mediated ubiquitination and degradation of p53; HMGB2 overexpression leads to G1 cell cycle arrest; this effect is specific to HPV-positive cells.\",\n      \"method\": \"Co-expression experiment, ubiquitination assay, siRNA knockdown, FACS cell cycle analysis\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct mechanistic experiment with ubiquitination assay, single lab\",\n      \"pmids\": [\"20036050\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"HMGB2 promotes neointimal hyperplasia and VSMC proliferation/migration by inducing reactive oxygen species through increased p47phox phosphorylation; HMGB2-induced effects are mediated via RAGE (receptor for advanced glycation end products) but not TLR4, as RAGE knockdown/deficiency but not TLR4 knockdown abolished HMGB2 effects.\",\n      \"method\": \"Hmgb2-/- mouse arterial injury model, perivascular HMGB2 administration, siRNA knockdown of p47phox and RAGE/TLR4, ROS measurement\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo KO plus in vitro mechanistic dissection with receptor and effector knockdown\",\n      \"pmids\": [\"28183701\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"HMGB2 promotes myocardial ischemic injury by stimulating ROS production via RAGE signaling, thereby aggravating cell apoptosis, inflammation, and autophagosome clearance impairment; RAGE knockdown abolishes HMGB2-induced effects.\",\n      \"method\": \"Intramyocardial injection of HMGB2 in MI rat model, NADPH oxidase inhibitor (apocynin) co-administration, RAGE knockdown\",\n      \"journal\": \"American journal of physiology. Heart and circulatory physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo injection model with inhibitor and receptor knockdown, single lab\",\n      \"pmids\": [\"28011583\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Hmgb2-/- mice show cardiac dysfunction due to AKT inactivation and decreased SERCA2a activity; HMGB2 loss worsens pressure overload-induced heart failure after TAC surgery, indicating HMGB2 plays a cardioprotective role via AKT/SERCA2a pathway.\",\n      \"method\": \"Hmgb2-/- knockout mouse, TAC surgery model, Western blot for AKT activation and SERCA2a activity, echocardiography\",\n      \"journal\": \"Circulation journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined molecular pathway, single lab\",\n      \"pmids\": [\"30487376\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"HMGB2 mediates adipogenesis by enhancing expression of C/EBPβ through direct binding to the 'GGGTCTCAC' sequence in its promoter specifically during the mitotic clonal expansion stage; exogenous C/EBPβ rescues adipogenic defects caused by HMGB2 inhibition.\",\n      \"method\": \"ChIP assay (HMGB2 binding to C/EBPβ promoter), Hmgb2-/- mouse, promoter reporter assay, rescue experiment\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP with defined binding sequence plus epistasis rescue, in vivo KO\",\n      \"pmids\": [\"34215724\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"HMGB2 is a transcriptional suppressor of latexin in hematopoietic stem cells; HMGB2 identified by DNA pull-down and mass spectrometry as binding the latexin promoter; HMGB2 knockdown increases latexin expression and decreases HSC number and regeneration; a functional SNP (rs31528793) in the latexin promoter affects HMGB2 binding and promoter activity.\",\n      \"method\": \"DNA pull-down followed by mass spectrometry, ChIP, siRNA knockdown, in vivo HSC number and regeneration assay, SNP promoter assay\",\n      \"journal\": \"Haematologica\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — DNA pull-down/MS identification plus ChIP, functional in vivo validation\",\n      \"pmids\": [\"31171637\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"HMGB2 is a negative regulator of telomerase activity in human embryonic stem cells and neuroectodermal progenitors; HMGB2 deficiency activates PI3K/AKT/GSK-3β/β-catenin signaling and augments TERT/TERC transcription; HMGB2 and HMGB1 have opposing roles in telomerase regulation.\",\n      \"method\": \"shRNA-mediated knockdown in stably transfected hESCs, telomerase activity assay, RT-PCR, Western blot, TERRA measurement\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — defined KD phenotype with pathway analysis, single lab\",\n      \"pmids\": [\"31661640\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"lnc-CRCMSL physically binds to HMGB2 (identified by RNA pulldown) and stabilizes HMGB2 in the cytoplasm; lnc-CRCMSL knockdown shifts HMGB2 to the nucleus where it triggers EMT programming by interacting with OCT4; nuclear export inhibitor (leptomycin B) counteracts lnc-CRCMSL-mediated suppression of EMT, confirming that cytoplasmic retention of HMGB2 is the key mechanism.\",\n      \"method\": \"RNA pulldown, subcellular fractionation, co-immunoprecipitation (HMGB2-OCT4), leptomycin B treatment, in vivo tumor model\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — RNA pulldown plus pharmacological validation of nucleocytoplasmic shuttling mechanism\",\n      \"pmids\": [\"30575817\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"HMGB2 regulates the differentiation and maintenance of stem-like progenitor exhausted CD8+ T cells (Tpex) during chronic viral infection and cancer through epigenetic and transcriptional programming; HMGB2 acts cell-intrinsically—despite Hmgb2-/- CD8+ T cells expressing TCF-1 and TOX, these master regulators cannot sustain Tpex differentiation.\",\n      \"method\": \"Hmgb2-/- mouse, chronic LCMV infection model, tumor model, single-cell transcriptomics, ATAC-seq epigenetic profiling\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO, in vivo chronic infection and tumor models, epigenetic profiling\",\n      \"pmids\": [\"37704621\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"NAT10-mediated N4-acetylcytidine (ac4C) modification within the coding sequence of HMGB2 mRNA enhances HMGB2 translation by facilitating eukaryotic elongation factor 2 (eEF2) binding to the ac4C sites.\",\n      \"method\": \"Acetylated RNA immunoprecipitation sequencing (acRIP-seq), ribosome profiling, RNA immunoprecipitation, RNA pull-down, mass spectrometry, site-specific mutation analysis\",\n      \"journal\": \"Cancer communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal methods including ribosome profiling, RNA pulldown, and site-specific mutagenesis\",\n      \"pmids\": [\"39030964\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"HMGB2 is predominantly expressed in the outer nuclear layer of the retina and is released to the cytoplasm after oxidative injury; exogenous HMGB2 reduces Nrf2 and HO-1 expression and activates the NF-κB/NLRP3 pathway; HMGB2 knockdown increases cell viability, up-regulates Nrf2/HO-1, and down-regulates pyroptosis-related proteins in H2O2-treated cells.\",\n      \"method\": \"Mouse light-induced retinal damage model, siRNA knockdown, recombinant HMGB2 protein treatment, Western blot, immunofluorescence\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo model plus in vitro gain/loss-of-function, single lab\",\n      \"pmids\": [\"35091064\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"HMGB2 is a non-histone chromatin architectural protein that bends and unwinds DNA via its two HMG box domains (box B being the primary DNA-recognition and conformational-change domain), facilitates assembly of nucleoprotein complexes (including RAG1/2-RSS, SET complex, and Lef-1/β-catenin), modulates transcription of specific gene programs (GFI1B in erythropoiesis, C/EBPβ in adipogenesis, SASP genes in senescence, topo IIα, and Runx2) by enhancing transcription factor binding at target promoters, undergoes acetylation that enables nucleosome binding and co-remodeling with SWI/SNF, shuttles between nucleus and cytoplasm (with cytoplasmic retention suppressing EMT), regulates 3D genome organization and CTCF clustering during senescence entry, acts as a cell-intrinsic epigenetic regulator of exhausted CD8+ T cell differentiation, and whose translation is controlled by NAT10-mediated ac4C mRNA modification via eEF2 recruitment.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"HMGB2 is a non-histone chromatin architectural protein that bends and unwinds DNA through its tandem HMG box domains—box B being the principal domain for DNA recognition and conformational change—thereby facilitating assembly of diverse nucleoprotein complexes and modulating transcription [PMID:628842, PMID:9888798, PMID:8339930]. It acts as a transcriptional co-regulator by enhancing transcription factor binding at target promoters (Oct-1 at GFI1B, NF-Y at topo IIα, Lef-1/β-catenin at Wnt targets, C/EBPβ during adipogenesis, SRC-1/ER in endocrine-resistant breast cancer), and its acetylation enables nucleosome binding and cooperative chromatin remodeling with SWI/SNF [PMID:19965638, PMID:19805379, PMID:19223331, PMID:34215724, PMID:25284587, PMID:19522541]. During cellular senescence, HMGB2 prevents heterochromatin spreading into SASP gene loci and its nuclear depletion triggers CTCF spatial clustering and 3D genome reorganization; in CD8+ T cells it functions as a cell-intrinsic epigenetic regulator required for stem-like progenitor exhausted T cell maintenance during chronic infection and cancer [PMID:27799366, PMID:29706538, PMID:37704621]. Hmgb2-knockout mice exhibit reduced male fertility with spermatogenic defects, accelerated osteoarthritis with superficial-zone chondrocyte apoptosis, and impaired muscle regeneration, establishing essential tissue-specific roles in germ cell differentiation, cartilage homeostasis, and myogenesis [PMID:11262228, PMID:19139395, PMID:27672022].\",\n  \"teleology\": [\n    {\n      \"year\": 1978,\n      \"claim\": \"Establishing that HMG proteins alter DNA topology resolved a fundamental question about whether non-histone chromosomal proteins could directly modify DNA structure, opening the field of HMG-mediated chromatin architecture.\",\n      \"evidence\": \"Topological winding number assay showing HMG1/2 reduce linking number of circular DNA\",\n      \"pmids\": [\"628842\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of unwinding (intercalation vs. bending) not yet resolved\", \"No domain dissection performed\"]\n    },\n    {\n      \"year\": 1979,\n      \"claim\": \"Quantifying unwinding angles (~26° per HMG2 molecule) and demonstrating preferential single-strand binding established that HMG proteins locally denature base pairs rather than merely wrapping DNA.\",\n      \"evidence\": \"Melting absorption technique and competition unwinding experiments\",\n      \"pmids\": [\"226939\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether unwinding reflects physiological function or is an in vitro artifact was unresolved\", \"Individual domain contributions unknown\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Demonstrating that HMG1/2 bend DNA into circles as small as 59–66 bp and that box B suffices for bending established the paradigm that HMGB proteins function as architectural facilitators of nucleoprotein complex assembly.\",\n      \"evidence\": \"Ligase-mediated circularization assay, invertasome assembly assay with domain dissection\",\n      \"pmids\": [\"8339930\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Box A function remained unclear\", \"In vivo relevance of DNA bending not yet shown\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Discovery that HMG2 acts as a basal repressor of RNA Pol II transcription—blocking elongation after pre-initiation complex formation—and that TFIIH counteracts this repression revealed a dual transcriptional regulatory role.\",\n      \"evidence\": \"Reconstituted in vitro transcription with order-of-addition and antibody depletion experiments\",\n      \"pmids\": [\"8007973\", \"7797075\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether repression and activation occur on the same promoters in vivo was unknown\", \"Mechanism of TFIIH-mediated relief not fully defined\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Identifying box B as the primary domain for DNA recognition and conformational change—with Phe-102 intercalation being critical—and showing that HMGB2 incorporates into RAG1/2-RSS complexes to enhance V(D)J recombination established two key paradigms: domain specialization and a direct role in adaptive immune receptor assembly.\",\n      \"evidence\": \"SPR kinetics, mutagenesis, supercoiling assays for domain function; co-IP, EMSA, circular permutation, and in vivo recombination assay for RAG interaction\",\n      \"pmids\": [\"9888798\", \"10490593\", \"10390537\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of box B–DNA interaction at atomic resolution not determined\", \"Relative contributions of HMGB1 vs HMGB2 in V(D)J recombination in vivo unclear\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Hmgb2-knockout mice revealed essential, non-redundant roles: male infertility with spermatocyte degeneration demonstrated that despite co-expression with HMGB1, HMGB2 has tissue-specific functions in germ cell differentiation.\",\n      \"evidence\": \"Hmgb2−/− mouse phenotyping with histology and immunostaining\",\n      \"pmids\": [\"11262228\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular targets of HMGB2 in spermatocytes not identified\", \"Whether phenotype reflects chromatin architecture vs. transcription regulation unknown\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Identification of HMGB2 as a SET complex component that provides DNA bending/looping activity and is specifically cleaved by granzyme A linked HMGB2 to the cytotoxic lymphocyte killing pathway and apoptotic DNA fragmentation.\",\n      \"evidence\": \"Co-immunoprecipitation, confocal colocalization at ER, in vitro granzyme A cleavage assay\",\n      \"pmids\": [\"11909973\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether granzyme A cleavage of HMGB2 is essential for target cell death in vivo not tested\", \"Stoichiometry within the SET complex undefined\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"A burst of discoveries established HMGB2 as a transcriptional co-activator at specific promoters (GFI1B, topo IIα, Lef-1/β-catenin targets), showed acetylation enables nucleosome binding and SWI/SNF co-remodeling, and revealed essential roles in chondrocyte survival and cartilage homeostasis via Wnt signaling.\",\n      \"evidence\": \"ChIP at GFI1B promoter with differentiation assay; siRNA/reporter for topo IIα; EMSA/reporter/KO mouse for Lef-1; nucleosome binding/remodeling assays with acetylated HMGB2; Hmgb2−/− mouse osteoarthritis model\",\n      \"pmids\": [\"19965638\", \"19223331\", \"19805379\", \"19522541\", \"19139395\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Acetyltransferase(s) responsible for HMGB2 acetylation in vivo not identified\", \"Whether nucleosome remodeling function operates at specific loci or genome-wide unknown\", \"Direct structural basis for acetylation-dependent nucleosome recognition unresolved\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"ChIP-seq and Hi-C revealed that HMGB2 preferentially occupies SASP gene loci during senescence, acting as an anti-silencing boundary that prevents heterochromatin spreading; separately, HMGB2 was shown to drive myogenesis through IGF2BP2-mediated post-transcriptional regulation of Myf5.\",\n      \"evidence\": \"ChIP-seq/Hi-C with siRNA in senescent fibroblasts; shRNA knockdown with IGF2BP2 rescue and in vivo muscle injury model\",\n      \"pmids\": [\"27799366\", \"27672022\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether HMGB2 directly recruits boundary factors or passively blocks heterochromatin unknown\", \"Mechanism by which HMGB2 transcriptionally activates IGF2BP2 not defined\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Nuclear depletion of HMGB2 was shown to be an early senescence event that triggers CTCF spatial clustering and 3D genome loop reorganization, establishing HMGB2 as a master regulator of genome topology during cellular aging; concurrently, cytoplasmic retention of HMGB2 by lnc-CRCMSL was found to suppress EMT by preventing nuclear HMGB2-OCT4 interaction.\",\n      \"evidence\": \"Hi-C, single-cell RNA-seq, HMGB2 knockdown/rescue across three cell types; RNA pulldown plus leptomycin B pharmacological validation\",\n      \"pmids\": [\"29706538\", \"30575817\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct molecular mechanism by which HMGB2 prevents CTCF clustering not defined\", \"Whether nucleocytoplasmic shuttling regulation differs across tissue types untested\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Discovery that HMGB2 cell-intrinsically regulates exhausted CD8+ T cell progenitor (Tpex) differentiation during chronic infection and cancer—independently of canonical TCF-1/TOX—revealed a new immune-epigenetic function with therapeutic implications.\",\n      \"evidence\": \"Hmgb2−/− mouse with chronic LCMV and tumor models, single-cell RNA-seq, ATAC-seq\",\n      \"pmids\": [\"37704621\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct chromatin targets of HMGB2 in Tpex cells not mapped\", \"Whether HMGB2 acts through CTCF reorganization in T cells as in senescence untested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identification of NAT10-mediated ac4C modification on HMGB2 mRNA CDS that enhances translation via eEF2 recruitment established a novel epitranscriptomic layer controlling HMGB2 protein abundance.\",\n      \"evidence\": \"acRIP-seq, ribosome profiling, RNA pulldown/mass spectrometry, site-specific mutagenesis\",\n      \"pmids\": [\"39030964\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether ac4C-mediated translational control is tissue-specific unknown\", \"Upstream signals regulating NAT10-dependent HMGB2 mRNA modification not identified\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: (1) how HMGB2 mechanistically prevents CTCF clustering and heterochromatin spreading at the molecular level, (2) which acetyltransferases modify HMGB2 in vivo and how this is regulated, (3) whether HMGB2's genome-topology and transcriptional co-activator functions are separable, and (4) the structural basis for promoter-specific recruitment.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No high-resolution structure of HMGB2 bound to a nucleosome or promoter complex\", \"No genome-wide binding data comparing HMGB2 occupancy across tissues and differentiation states\", \"Functional redundancy with HMGB1 incompletely dissected\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 1, 2, 9, 14]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [3, 4, 17, 19, 25, 32]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [2, 12, 14]},\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [18]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [5, 13, 25, 27]},\n      {\"term_id\": \"GO:0005694\", \"supporting_discovery_ids\": [13, 25]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [12, 35]},\n      {\"term_id\": \"GO:0005654\", \"supporting_discovery_ids\": [5, 27]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [3, 4, 17, 19, 25, 32]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [18, 25, 27]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [7, 8, 36]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [6, 12]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [11, 19, 26]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [16, 20, 29]}\n    ],\n    \"complexes\": [\n      \"SET complex\",\n      \"RAG1/RAG2-RSS complex\",\n      \"SRC-1/ER complex\"\n    ],\n    \"partners\": [\n      \"RAG1\",\n      \"SET\",\n      \"LEF1\",\n      \"SRC1\",\n      \"ESR1\",\n      \"OCT4\",\n      \"CTCF\",\n      \"IGF2BP2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}